144 related articles for article (PubMed ID: 8540731)
1. Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin.
Hasegawa T; Yamaki K; Muraoka I; Nadai M; Takagi K; Nabeshima T
Antimicrob Agents Chemother; 1995 Sep; 39(9):2135-7. PubMed ID: 8540731
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers.
Hasegawa T; Yamaki K; Nadai M; Muraoka I; Wang L; Takagi K; Nabeshima T
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):57-61. PubMed ID: 8004359
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of multiple intravenous instillation of levofloxacin in Chinese healthy subjects.
Zhang L; Li JT; Lu Y; Li MN; Zhang YL; Liu Y; Li TY; Zhang JW
Acta Pharmacol Sin; 2002 Apr; 23(4):381-4. PubMed ID: 11931699
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
5. Interaction between levofloxacin and vancomycin in rats--study of serum and organ levels.
Mori H; Nakajima T; Nakayama A; Yamori M; Izushi F; Gomita Y
Chemotherapy; 1998; 44(3):181-9. PubMed ID: 9612608
[TBL] [Abstract][Full Text] [Related]
6. Effect of bile duct ligation and unilateral nephrectomy on brain concentration and convulsant potential of the quinolone antibacterial agent levofloxacin in rats.
Akahane K; Ohkawara S; Nomura M; Kato M
Fundam Appl Toxicol; 1996 Feb; 29(2):280-6. PubMed ID: 8742326
[TBL] [Abstract][Full Text] [Related]
7. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
[TBL] [Abstract][Full Text] [Related]
8. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
9. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit.
Rebuck JA; Fish DN; Abraham E
Pharmacotherapy; 2002 Oct; 22(10):1216-25. PubMed ID: 12389872
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
[TBL] [Abstract][Full Text] [Related]
14. Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases.
Tanigawara Y; Nomura H; Kagimoto N; Okumura K; Hori R
Biol Pharm Bull; 1995 Feb; 18(2):315-20. PubMed ID: 7742805
[TBL] [Abstract][Full Text] [Related]
15. Concentration of levofloxacin in cervical mucus and its clinical effects on cervicitis.
Chimura T; Arai M; Onuma Y; Oda T; Kawagoe S; Kunii K; Saito T; Saito N; Sato F; Numazaki M; Matsuo M; Murayama K; Morizaki N
Jpn J Antibiot; 1997 Nov; 50(11):871-7. PubMed ID: 9651605
[TBL] [Abstract][Full Text] [Related]
16. Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.
Chien SC; Chow AT; Natarajan J; Williams RR; Wong FA; Rogge MC; Nayak RK
Antimicrob Agents Chemother; 1997 Jul; 41(7):1562-5. PubMed ID: 9210685
[TBL] [Abstract][Full Text] [Related]
17. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.
Chow AT; Fowler C; Williams RR; Morgan N; Kaminski S; Natarajan J
Antimicrob Agents Chemother; 2001 Jul; 45(7):2122-5. PubMed ID: 11408234
[TBL] [Abstract][Full Text] [Related]
18. Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects.
Lee LJ; Hafkin B; Lee ID; Hoh J; Dix R
Antimicrob Agents Chemother; 1997 Oct; 41(10):2196-200. PubMed ID: 9333047
[TBL] [Abstract][Full Text] [Related]
19. Tissue penetration of a single dose of levofloxacin intravenously for antibiotic prophylaxis in lung surgery.
von Baum H; Böttcher S; Hoffmann H; Sonntag HG
J Antimicrob Chemother; 2001 May; 47(5):729-30. PubMed ID: 11328803
[No Abstract] [Full Text] [Related]
20. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
